FI751108A - - Google Patents

Info

Publication number
FI751108A
FI751108A FI751108A FI751108A FI751108A FI 751108 A FI751108 A FI 751108A FI 751108 A FI751108 A FI 751108A FI 751108 A FI751108 A FI 751108A FI 751108 A FI751108 A FI 751108A
Authority
FI
Finland
Application number
FI751108A
Other languages
Finnish (fi)
Other versions
FI62220C (fi
FI62220B (fi
Inventor
Donald Charles Monkhouse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI751108A publication Critical patent/FI751108A/fi
Application granted granted Critical
Publication of FI62220B publication Critical patent/FI62220B/fi
Publication of FI62220C publication Critical patent/FI62220C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI751108A 1974-04-19 1975-04-15 Foerfarande foer stabilisering av en prostaglandin av e-serieninnehaollande farmaseutisk blandning FI62220C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins
US46221374 1974-04-19

Publications (3)

Publication Number Publication Date
FI751108A true FI751108A (US08124317-20120228-C00060.png) 1975-10-20
FI62220B FI62220B (fi) 1982-08-31
FI62220C FI62220C (fi) 1982-12-10

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751108A FI62220C (fi) 1974-04-19 1975-04-15 Foerfarande foer stabilisering av en prostaglandin av e-serieninnehaollande farmaseutisk blandning

Country Status (23)

Country Link
US (1) US3927197A (US08124317-20120228-C00060.png)
JP (1) JPS5337408B2 (US08124317-20120228-C00060.png)
AR (1) AR213271A1 (US08124317-20120228-C00060.png)
AT (1) AT348130B (US08124317-20120228-C00060.png)
AU (1) AU470631B2 (US08124317-20120228-C00060.png)
BE (1) BE828065A (US08124317-20120228-C00060.png)
BG (1) BG35326A3 (US08124317-20120228-C00060.png)
CA (1) CA1034044A (US08124317-20120228-C00060.png)
CS (1) CS191244B2 (US08124317-20120228-C00060.png)
DD (1) DD119131A5 (US08124317-20120228-C00060.png)
DE (1) DE2516105C3 (US08124317-20120228-C00060.png)
DK (1) DK138161B (US08124317-20120228-C00060.png)
ES (1) ES436613A1 (US08124317-20120228-C00060.png)
FI (1) FI62220C (US08124317-20120228-C00060.png)
FR (1) FR2267760B1 (US08124317-20120228-C00060.png)
GB (1) GB1474852A (US08124317-20120228-C00060.png)
HU (1) HU175405B (US08124317-20120228-C00060.png)
IE (1) IE40829B1 (US08124317-20120228-C00060.png)
IL (1) IL46994A (US08124317-20120228-C00060.png)
LU (1) LU72320A1 (US08124317-20120228-C00060.png)
NL (1) NL158384B (US08124317-20120228-C00060.png)
PH (1) PH11697A (US08124317-20120228-C00060.png)
SE (1) SE428528B (US08124317-20120228-C00060.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (US08124317-20120228-C00060.png) 1976-03-17
PH11697A (en) 1978-05-24
JPS5337408B2 (US08124317-20120228-C00060.png) 1978-10-09
IE40829B1 (en) 1979-08-29
CS191244B2 (en) 1979-06-29
ES436613A1 (es) 1977-04-16
SE428528B (sv) 1983-07-11
DK138161B (da) 1978-07-24
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (US08124317-20120228-C00060.png) 1975-10-20
JPS50145515A (US08124317-20120228-C00060.png) 1975-11-21
AU470631B2 (en) 1976-03-25
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (US08124317-20120228-C00060.png) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (US08124317-20120228-C00060.png) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
DD119131A5 (US08124317-20120228-C00060.png) 1976-04-12
AU7987775A (en) 1976-03-25
DK138161C (US08124317-20120228-C00060.png) 1979-01-02

Similar Documents

Publication Publication Date Title
FR2261780A1 (US08124317-20120228-C00060.png)
CS167146B1 (US08124317-20120228-C00060.png)
FR2270051A1 (US08124317-20120228-C00060.png)
FR2267760B1 (US08124317-20120228-C00060.png)
FR2282306B1 (US08124317-20120228-C00060.png)
FR2265901B1 (US08124317-20120228-C00060.png)
CS178026B1 (US08124317-20120228-C00060.png)
FR2259577B1 (US08124317-20120228-C00060.png)
FR2291272B1 (US08124317-20120228-C00060.png)
FR2282013B3 (US08124317-20120228-C00060.png)
HU168700B (US08124317-20120228-C00060.png)
JPS50101329U (US08124317-20120228-C00060.png)
FI740151A0 (US08124317-20120228-C00060.png)
DK67375A (US08124317-20120228-C00060.png)
BG23188A1 (US08124317-20120228-C00060.png)
BG21503A1 (US08124317-20120228-C00060.png)
CH1107074A4 (US08124317-20120228-C00060.png)
BG26152A1 (US08124317-20120228-C00060.png)
CH581510A5 (US08124317-20120228-C00060.png)
BG22732A1 (US08124317-20120228-C00060.png)
BG22484A1 (US08124317-20120228-C00060.png)
BG22309A1 (US08124317-20120228-C00060.png)
BG19828A1 (US08124317-20120228-C00060.png)
BG19873A1 (US08124317-20120228-C00060.png)
BG22203A1 (US08124317-20120228-C00060.png)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: PFIZER INC.